These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37894870)

  • 21. Green tea inhibited the elimination of nephro-cardiovascular toxins and deteriorated the renal function in rats with renal failure.
    Peng YH; Sweet DH; Lin SP; Yu CP; Lee Chao PD; Hou YC
    Sci Rep; 2015 Nov; 5():16226. PubMed ID: 26552961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease.
    Summers SC; Quimby JM; Isaiah A; Suchodolski JS; Lunghofer PJ; Gustafson DL
    J Vet Intern Med; 2019 Mar; 33(2):662-669. PubMed ID: 30561098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
    Mutsaers HA; van den Heuvel LP; Ringens LH; Dankers AC; Russel FG; Wetzels JF; Hoenderop JG; Masereeuw R
    PLoS One; 2011 Apr; 6(4):e18438. PubMed ID: 21483698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Translation of Microfluidic Transporter
    van der Made TK; Fedecostante M; Scotcher D; Rostami-Hodjegan A; Sastre Toraño J; Middel I; Koster AS; Gerritsen KG; Jankowski V; Jankowski J; Hoenderop JGJ; Masereeuw R; Galetin A
    Mol Pharm; 2019 Nov; 16(11):4551-4562. PubMed ID: 31525064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
    Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J
    Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS.
    Lin CN; Wu IW; Huang YF; Peng SY; Huang YC; Ning HC
    J Food Drug Anal; 2019 Apr; 27(2):502-509. PubMed ID: 30987721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice.
    Caggiano G; Amodio L; Stasi A; Colabufo NA; Colangiulo S; Pesce F; Gesualdo L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of human organic anion as well as cation transporters with indoxyl sulfate.
    Enomoto A; Takeda M; Taki K; Takayama F; Noshiro R; Niwa T; Endou H
    Eur J Pharmacol; 2003 Apr; 466(1-2):13-20. PubMed ID: 12679137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin enhances p-cresyl sulfate-induced cytotoxic effects on renal tubular cells.
    Wei CW; Wu TK; Wu SC; Chen YL; Pan YR; Chien YC; Wu JY; Yu YL; Yiang GT
    Int J Med Sci; 2022; 19(7):1138-1146. PubMed ID: 35919818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure.
    Taki K; Nakamura S; Miglinas M; Enomoto A; Niwa T
    J Ren Nutr; 2006 Jul; 16(3):199-203. PubMed ID: 16825019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin.
    Watanabe H; Noguchi T; Miyamoto Y; Kadowaki D; Kotani S; Nakajima M; Miyamura S; Ishima Y; Otagiri M; Maruyama T
    Drug Metab Dispos; 2012 Jul; 40(7):1423-8. PubMed ID: 22513409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between Dental Scores and Saliva Uremic Toxins.
    Rigothier C; Catros S; Bénard A; Samot J; Quintin O; Combe C; Larabi I; Massy Z; Alvarez JC
    Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.
    Wu W; Bush KT; Nigam SK
    Sci Rep; 2017 Jul; 7(1):4939. PubMed ID: 28694431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate.
    Summers S; Quimby JM; Phillips RK; Stockman J; Isaiah A; Lidbury JA; Steiner JM; Suchodolski J
    J Vet Intern Med; 2020 Jan; 34(1):206-215. PubMed ID: 31693251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure.
    Di Paola R; De A; Izhar R; Abate M; Zappavigna S; Capasso A; Perna AF; La Russa A; Capasso G; Caraglia M; Simeoni M
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients.
    Gryp T; Huys GRB; Joossens M; Van Biesen W; Glorieux G; Vaneechoutte M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3.
    Hsueh CH; Yoshida K; Zhao P; Meyer TW; Zhang L; Huang SM; Giacomini KM
    Mol Pharm; 2016 Sep; 13(9):3130-40. PubMed ID: 27467266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
    Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
    J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
    Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
    Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of uremic toxin transport by organic anion transporters in the kidney.
    Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
    Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.